drugset / Trial / NCT05011669
The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of Lurasidone initiated with 40mg and 80mg in treatment with acute phase patients with schizophrenia
Timeline
- Start
- 2021-08-16
- Primary completion
- 2023-04-16
- Completion
- 2023-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 40 mg | Oral |
| Subject | Lurasidone | Small molecule | 80 mg | Oral |